Table 2. Top 15 Organizations with Patent Applications on RNA Therapeutics or Vaccinesa.
| Ranking | Organizations | No. of patent applications | Country | Organization type | No. of patent applications in the past 3 years (% of total) |
|---|---|---|---|---|---|
| 1 | Moderna | 207 | U.S. | Company | 61 (29.5%) |
| 2 | CureVac | 150 | Germany | Company | 15 (10.0%) |
| 3 | BioNTech | 135 | Germany | Company | 59 (43.7%) |
| 4 | Translate Bio | 78 | U.S. | Company | 48 (61.5%) |
| 5 | Tron | 53 | Germany | Company | 11 (20.8%) |
| 6 | Alnylam Pharmaceuticals | 30 | U.S. | Company | 2 (6.7%) |
| 7 | Shire Human Genetic Therapies | 28 | U.S. | Company | 0 (0.0%) |
| 8 | University of Pennsylvania | 27 | U.S. | University | 13 (48.1%) |
| 9 | Arcturus Therapeutics | 23 | U.S. | Company | 8 (34.8%) |
| 10 | Acuitas Therapeutics | 21 | Canada | Company | 5 (23.8%) |
| 11 | Chinese Academy of Sciences | 17 | China | Scientific research institution | 12 (70.6%) |
| 12 | Massachusetts Institute of Technology | 16 | U.S. | University | 4 (25.0%) |
| 12 | University of California | 16 | U.S. | University | 6 (37.5%) |
| 14 | Ethris | 15 | Germany | Company | 2 (13.3%) |
| 15 | Evox Therapeutics | 14 | U.K. | Company | 4 (28.6%) |
a
Data from the CAS Content Collection.